Skip Header

1 - 25 of 30 results for author:"Buraczynska M." in Literature citations

Page of 2 | Next »

to top of page·  

Results Customize

› Repeat search in UniProtKB (2)

The intercellular adhesion molecule-1 (ICAM-1) gene polymorphism K469E in end-stage renal disease patients with cardiovascular disease.

Buraczynska M., Zaluska W., Baranowicz-Gaszczyk I., Buraczynska K., Niemczyk E., Ksiazek A.

Hum. Immunol. 73:824-828(2012) · Mapped (9)

Chemotactic cytokine receptor 5 gene polymorphism: relevance to microvascular complications in type 2 diabetes.

Buraczynska M., Zukowski P., Wacinski P., Berger-Smyka B., Dragan M., Mozul S.

Cytokine 58:213-217(2012) · Mapped (22)

Renalase gene polymorphisms in patients with type 2 diabetes, hypertension and stroke.

Buraczynska M., Zukowski P., Buraczynska K., Mozul S., Ksiazek A.

Neuromolecular Med. 13:321-327(2011) · Mapped (2)

Transcription factor 7-like 2 (TCF7L2) gene polymorphism and complication/comorbidity profile in type 2 diabetes patients.

Buraczynska M., Swatowski A., Markowska-Gosik D., Kuczmaszewska A., Ksiazek A.

Diabetes Res. Clin. Pract. 93:390-395(2011) · Mapped (31)

Complement receptor 1 gene polymorphism and cardiovascular disease in dialyzed end-stage renal disease patients.

Buraczynska M., Ksiazek P., Wacinski P., Zukowski P., Dragan M., Bednarek-Skublewska A.

Hum. Immunol. 71:878-882(2010) · Mapped (26)

Complement factor H gene polymorphism and risk of cardiovascular disease in end-stage renal disease patients.

Buraczynska M., Ksiazek P., Zukowski P., Benedyk-Lorens E., Orlowska-Kowalik G.

Clin. Immunol. 132:285-290(2009) · Mapped (5)

Toll-like receptor 4 gene polymorphism and early onset of diabetic retinopathy in patients with type 2 diabetes.

Buraczynska M., Baranowicz-Gaszczyk I., Tarach J., Ksiazek A.

Hum. Immunol. 70:121-124(2009) · Mapped (2)

Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for cardiovascular disease in hemodialyzed patients.

Buraczynska M., Bednarek-Skublewska A., Buraczynska K., Ksiazek A.

Cytokine 44:361-365(2008) · Mapped (3)

Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes.

Buraczynska M., Swatowski A., Buraczynska K., Dragan M., Ksiazek A.

Clin. Sci. 116:81-86(2009) · Mapped (18)

Tumor necrosis factor-alpha gene polymorphism correlates with cardiovascular disease in patients with end-stage renal disease.

Buraczynska M., Mierzicki P., Buraczynska K., Dragan M., Ksiazek A.

Mol Diagn Ther 11:257-263(2007) · Mapped (6)

Interleukin-6 gene polymorphism and faster progression to end-stage renal failure in chronic glomerulonephritis.

Buraczynska M., Jozwiak L., Ksiazek P., Borowicz E., Mierzicki P.

Transl Res 150:101-105(2007) · Mapped (5)

TGF-beta1 and TSC-22 gene polymorphisms and susceptibility to microvascular complications in type 2 diabetes.

Buraczynska M., Baranowicz-Gaszczyk I., Borowicz E., Ksiazek A.

Nephron Physiol 106:p69-75(2007) · Mapped (11)

Interleukin-1 receptor antagonist gene polymorphism affects the progression of chronic renal failure.

Buraczynska M., Ksiazek P., Kubit P., Zaluska W.

Cytokine 36:167-172(2006) · Mapped (4)

Norepinephrine transporter gene (NET) polymorphism in patients with type 2 diabetes.

Ksiazek P., Buraczynska K., Buraczynska M.

Kidney Blood Press. Res. 29:338-343(2006) · Mapped (10)

Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients.

Buraczynska M., Ksiazek P., Baranowicz-Gaszczyk I., Jozwiak L.

Nephrol. Dial. Transplant. 22:827-832(2007) · Mapped (7)

Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease.

Buraczynska M., Ksiazek P., Drop A., Zaluska W., Spasiewicz D., Ksiazek A.

Nephrol. Dial. Transplant. 21:979-983(2006) · Mapped (14)

The -308 promoter polymorphism in the tumour necrosis factor gene in patients with lichen planus.

Krasowska D., Chodorowska G., Koziol-Montewka M., Ksiazek A., Buraczynska M.

Acta Derm. Venereol. 85:400-403(2005) · Mapped (6)

Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration.

Zareparsi S., Buraczynska M., Branham K.E.H., Shah S., Eng D., Li M., Pawar H., Yashar B.M., Moroi S.E., Lichter P.R. et al.

Hum. Mol. Genet. 14:1449-1455(2005) · UniProtKB (1) · Mapped (13)

Association of the human bradykinin B2 receptor gene with chronic renal failure.

Jozwiak L., Drop A., Buraczynska K., Ksiazek P., Mierzicki P., Buraczynska M.

Mol. Diagn. 8:157-161(2004) · Mapped (3)

Endothelial nitric oxide synthase gene intron 4 polymorphism in patients with end-stage renal disease.

Buraczynska M., Ksiazek P., Zaluska W., Nowicka T., Ksiazek A.

Nephrol. Dial. Transplant. 19:2302-2306(2004) · Mapped (7)

The C677T methylenetetrahydrofolate reductase gene mutation and nephropathy in type 2 diabetes mellitus.

Ksiazek P., Bednarek-Skublewska A., Buraczynska M.

Med. Sci. Monit. 10:BR47-51(2004) · Mapped (8)

Endothelial nitric oxide synthase gene intron 4 polymorphism in type 2 diabetes mellitus.

Ksiazek P., Wojewoda P., Muc K., Buraczynska M.

Mol. Diagn. 7:119-123(2003) · Mapped (7)

Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease.

Buraczynska M., Pijanowski Z., Spasiewicz D., Nowicka T., Sodolski T., Widomska - Czekajska T., Ksiazek A.

Kardiol Pol 58:1-9(2003) · Mapped (5)

Genetic polymorphisms of renin-angiotensin system and progression of interstitial nephritis.

Buraczynska M., Grzebalska A., Spasiewicz D., Orlowska G., Ksiazek A.

Ann Univ Mariae Curie Sklodowska Med 57:330-336(2002) · Mapped (14)

Association of the renin-angiotensin system gene polymorphism with nephropathy in type II diabetes.

Buraczynska M., Ksiazek P., Lopatynski J., Spasiewicz D., Nowicka T., Ksiazek A.

Pol. Arch. Med. Wewn. 108:725-730(2002) · Mapped (14)

to top of page·

Page of 2 | Next »